After insider trading scandal, US congressman drops campaign — but stays on the ballot; Junshi Biosciences applies for Hong Kong IPO
→ The US congressman who was charged with insider trading on a biotech stock last week has suspended his campaign for re-election. New York GOP …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
